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ease and enhances the survival of pancreatic islet allo-Mary K. Kennedy,* William C. Fanslow,*
Steven G. Reed,² and Charles R. Maliszewski* grafts (Durie et al., 1994; Buhlmann et al., 1995; Parker
et al., 1995). In addition, resolution of Pneumocystis*Department of Cellular Immunology
Department of Immunobiology carinii pneumonia in mice requires CD40L (Wiley and
Harmsen, 1995).Immunex Corporation
51 University Street In this study, we investigated whether CD40L is in-
volved in the immunoregulatory processes that occurSeattle, Washington 98101
²Infectious Disease Research Institute during a T cell±mediated response to Leishmania major.
The outcome of L. major infection in various inbred1124 Columbia Street, Suite 464
Seattle, Washington 98104 strains of mice correlates with the differential develop-
ment of CD41 T lymphocyte subsets exhibiting distinc-
tive cytokine profiles (Reiner and Locksley, 1995). Reso-
lution of leishmaniasis is associated with the expansionSummary
of interferon-g (IFNg)-secreting Th1 cells (Scott et al.,
1988; Heinzel et al., 1989; Holaday et al., 1991). Interleu-The CD40±CD40 ligand (CD40L) signaling process is
kin-12 (IL-12) is required for disease resistance (Heinzela pivotal component of multiple immunoregulatory
et al., 1995), perhaps owing to its ability to down-regu-pathways. Although the role that CD40L plays in hu-
late Th2 responses and drive polarization of CD41 T cellmoral immune responses is fairly well defined, its func-
differentiation toward the Th1 lineage (Hsieh et al., 1993;tion(s) in cell-mediated responses in vivo has not been
Seder et al., 1993). In this study, we used a CD40L-established. We investigated this issue by assessing
deficient mouse model to demonstrate that contact-the course of Leishmania major infection in CD40L
dependent signals mediated by CD40L are also neces-knockout (CD40LKO) mice that were generated on a
sary to establish a Th1-like response to L. major. Theresistant background. In response to parasite chal-
susceptibility of CD40L knockout (CD40LKO) mice tolenge, CD40LKO mice developed ulcerating cutane-
progressive infection is associated with a defect in theous lesions and failed to mount a vigorous Th1-like
ability of these animals to produce IFNg and IL-12. IL-response. The impaired Th1-like response appears to
12 administration restores a resistant phenotype tobe related to a defect in the ability of CD40LKO T cells
CD40LKO mice. The results suggest that in vivo estab-to induce the production of IL-12 from macrophages.
lishment of a protective cell-mediated immune responseTreatment with exogenous IL-12 prevented disease
to L. major requires CD40L-mediated stimulation ofprogression in CD40LKO mice, and administration
macrophage IL-12 production.of recombinant CD40L provided partial protection
against infection. Thus, a protective cell-mediated im-
mune response to L. major appears to be dependent Results
upon CD40L-induced IL-12 secretion by antigen-pre-
senting cells. CD40LKO Mice Are Susceptible to L. major
Infection and Fail to Generate a Predominant
Th1-Like ResponseIntroduction
We measured progression of L. major infection in
CD40LKO mice, which were bred on a genetic back-CD40 ligand (CD40L) is a 33 kDa glycoprotein expressed
on activated CD41 T lymphocytes (Armitage et al., 1992; ground composed of two resistant strains, C57BL/6 and
129/J (Renshaw et al., 1994). Control (C57BL/6 3 129/Lane et al., 1992; Spriggs et al., 1992). Its receptor,
CD40, is found on B cells, dendritic cells, monocytes, J)F1 animals retained the resistant phenotype of the
parental strains, as demonstrated by self-limiting in-and other cell types (Banchereau et al., 1994). The cog-
nate interaction of CD40L with CD40 on B lymphocytes creases in footpad swelling at the site of promastigote
inoculation (Figure 1). In contrast, CD40LKO mice failedis essential for germinal center formation, isotype
switching, and memory B cell generation (Foy et al., to resist L. major infection (Figures 1A±1B) and, like the
susceptible strain BALB/c, developed ulcerating lesions1993; Kawabe et al., 1994; Renshaw et al., 1994; Xu et
al., 1994). Defects in the CD40L gene are responsible within 7 weeks of initial parasite challenge.
To assess the Th effector cell phenotype in thesefor X-linked hyper-IgM syndrome (HIGM) (Callard et al.,
1993), a condition characterized by severely compro- animals, in vitro cytokine production was measured. Un-
fractionated popliteal lymph node cells from long-termmised humoral immunity. Enhanced susceptibility of
HIGM patients to opportunistic infections, such as infected (C57BL/6 3 129/J)F1, BALB/c, and CD40LKO
mice were stimulated with a soluble leishmanial antigenPneumocystis pneumonia and Cryptosporidium diar-
rhea (Notarangelo et al., 1992), also suggests a role preparation (SLA) or with immobilized anti-CD3 MAb for
72 hr. Culture supernatants collected from three sepa-for CD40±CD40L interactions in cell-mediated immune
responses. Further support is provided by studies in rate experiments were analyzed for IL-4 and IFNg levels
(Table 1). T cells from resistant (C57BL/6 3 129/J)F1which treatment of mice with anti-CD40L monoclonal
antibody (MAb) not only induces tolerance to allogeneic mice secreted high levels of IFNg in response to both
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Table 1. In Vitro Cytokine Secretion Profiles of Popliteal Lymph
Node Cells Isolated from Mice Infected with L. major
IFN g IL-4
Experiments (ng/ml)a (pg/ml)b
SLA Anti-CD3 SLA Anti-CD3
Experiment 1
(C57BL/6 X 129/J)F1 951 769 NDc ND
CD40LKO 6 76 22 ND
BALB/c 38 229 74 84
Experiment 2
(C57BL/6 X 129/J)F1 45 167 ND ND
CD40LKO 16 147 36 62
BALB/c 15 93 32 218
Experiment 3
(C57BL/6 X 129/J)F1 112 552 ND ND
CD40LKO 2 204 61 285
BALB/c 14 191 199 482
a Sensitivity of IFN g ELISA, 0.1±0.3 ng/ml.
b Sensitivity of the IL-4 ELISA for experiment 1, 15 pg/ml; experiment
2, 8±16 pg/ml; and experiment 3, 16±32 pg/ml.
c ND, not detectable; below limits of sensitivity.
requires both CD40L- and IFNg-dependent signals (Shu
et al., 1995; Kennedy et al., 1996). T cell receptor (TCR)-
activated T cells from uninfected CD40LKO mice have
a defect in their ability to induce macrophage IL-12 pro-
duction, yet retain the ability to produce IFNg and IL-2
(Kennedy et al., 1996). This observation prompted us to
investigate whether antigen-specific IL-12 production
is compromised in L. major±infected mice. As ex-
pected, anti-CD3-stimulated splenocytes from infected
CD40LKO mice produced 11- to 15-fold lower levels of
IL-12 than anti-CD3-stimulated splenocytes from in-
fected (C57BL/6 3 129/J)F1 and BALB/c mice (Figure
2A). With regard to an antigen-specific response, we
were unable to detect IL-12 in supernatants from unfrac-
tionated lymph node cells or splenocytes activated withFigure 1. CD40LKO Mice Are Susceptible to L. major Infection
SLA, regardless of whether the cells were obtained from(A) 129/J, C57BL/6, and CD40LKO mice or (B) (C57BL/6 3 129/J)F1,
BALB/c, and CD40LKO mice were injected with 2 3 105 stationary- infected control or CD40LKO mice. We attributed this
phase promastigotes in the hind footpad. The course of infection inability to the low percentage of antigen-presenting
was monitored by measuring footpad swelling three times weekly. cells (APCs) in the tissue preparations. To circumvent
Each data point represents the mean change in footpad thick-
this problem, lymph node cells were cocultured withness 6 SEM for 4±5 mice/group.
peritoneal macrophages from the same animals in the
presence of SLA (Figure 2B). Exogenous IFNg and a
neutralizing anti-IL-10 MAb were added to each culturestimuli. In contrast, T cells from CD40LKO mice secreted
up to 150-fold less IFNg in response to specific antigen to eliminate the possibility that variations in the level of
IFNg or IL-10 in the cultures would influence the produc-and as much as 10-fold less IFNg in response to anti-
CD3. Cultures of cells from CD40LKO mice contained tion of IL-12. IL-12 was detected in supernatants from
cultures containing SLA-stimulated lymph node cellshigher levels of IL-4 relative to (C57BL/6 3 129/J)F1
cultures and reduced quantities of both IFNg and IL-4 and peritoneal macrophages from L. major±infected
BALB/c or (C57BL/6 3 129/J)F1 mice but was not de-compared with BALB/c cultures. All infected mice had
similar percentages of CD31 cells and normal ratios of tected in similar cultures from infected CD40LKO mice.
The lack of IL-12 production in the CD40LKO culturesCD41 and CD81 subpopulations in their draining lymph
nodes (data not shown), indicating that the lower cyto- was apparently due to a defect at the level of the T cell,
because peritoneal macrophages from CD40LKO micekine levels inCD40LKO cellcultures cannotbe attributed
to a difference in absolute number of T cells present in produced IL-12 when cultured in the presence of lymph
node cells from infected (C57BL/6 3 129/J)F1 mice (Fig-those cultures.
ure 2B).
Direct evidence that macrophages from CD40LKOT Cells from L. major±Infected CD40LKO
Mice Fail to Induce IL-12 Production mice are not inherently defective in their ability to pro-
duce IL-12 is shown in Figure 3. We have previouslyby Macrophages
Activated T cells stimulate the production of IL-12 by shown that peritoneal macrophages from normal
C57BL/6 mice produce IL-12 in response to stimulationmonocytes/macrophages in vitro via a mechanism that
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Figure 3. IL-12 Secretion by Adherent Macrophages in a T Cell±Free
System
Adherent peritoneal macrophages obtained from uninfected
(C57BL/6 3 129/J)F1, BALB/c, and CD40LKO mice were cultured
for 20 hr with 1 mg/ml anti-IL-10 and 2 mg/ml indomethacin in the
presence of rCD40L (30 mg/ml), LPS (3 ng/ml), IFNg (20 ng/ml),
and GM±CSF (20 ng/ml) as indicated. IL-12 was not detected in
supernatants of macrophages stimulated with IFNg and GM±CSF.
Low levels (1±3pg/ml) of IL-12 were detected in response to stimula-
tion with either LPS or CD40L alone. Data are representative of
two experiments, and culture supernatants were analyzed for the
presence of IL-12 by bioassay as described in Experimental Proce-
dures.
a causative link between CD40L deficiency and disease
susceptibility. Thus, we addressed whether administra-
tion of exogenous IL-12 could bypass the requirement
Figure 2. T Cell±Dependent Induction of IL-12 Production for CD40L and elicit a protective cell-mediated immune
(A and B) Data are representative of two separate experiments, and response. CD40LKO mice were treated with two differ-
culture supernatants were analyzed for the presence of IL-12 by ent doses of mouse IL-12 for 7 consecutive days, begin-
bioassay. ning on the day of inoculation with L. major promasti-
(A) Splenocytes harvested from (C57BL/6 3 129/J)F1, BALB/c, and
gotes. Intraperitoneal administration of 1 mg/day IL-12CD40LKO mice (4±5/group) 1 week postinfection with L. major were
to CD40LKO mice provided complete protection fromstimulated in vitro for 20 hr with immobilized anti-CD3 MAb.
infection (Figure 4A). As reported previously, treatment(B) Adherent peritoneal macrophages obtained from (C57BL/6 3
129/J)F1, BALB/c, and CD40LKO 1 week postinfection were plated with 0.5 mg/day IL-12 enables BALB/c mice to resist L.
at 2 3 105 cells/well and cultured for 20 hr with lymph node cells major and cure the infection (Heinzel et al., 1993). This
(4 3 105 cells) in the presence of 25 mg/ml SLA, 20 ng/ml IFNg, 1 amount of exogenously administered IL-12 provided
mg/ml anti-IL-10, and 2 mg/ml indomethacin.
only partial protection to CD40LKO mice, and footpad
swelling increased significantly after4 weeks. In infected
CD40LKO mice, IL212-dependent reductions in footpadwith soluble CD40L in combination with IFNg, and that
this response can be enhanced by granulocyte/macro- lesion size correlated with reductions in tissue parasite
burden. Viable promastigotes were recovered at 1026±phage colony-stimulating factor (GM±CSF) (Kennedy et
al., 1996). Macrophages from uninfected CD40LKO, 1028 dilutions for untreated CD40LKO mice, at 1024±1025
for CD40LKO mice treated with 0.5 mg/day IL-12, andBALB/c, and (C57BL/6 3 129/J)F1 mice all produced
IL-12 in response to stimulation with either CD40L or at 1021 for CD40LKO mice treated with 1 mg/day IL-12.
No viable parasites could be recovered from the footpadlipopolysaccharide (LPS) in combination with IFNg and
GM±CSF. Although macrophages from all three strains tissue of (C57BL/6 3 129/J)F1 mice.
To assess whether IL-12 administration altered CD41of mice produced equivalent levels of IL-12 in response
to stimulation with LPS, the magnitude of the response T cell differentiation in infected CD40LKO mice, lymph
node cells from control and IL-12-treated mice wereto CD40L varied among the three strains.
stimulated in vitro with SLA, and IFNg production was
measured. In cultures of cells from IL-12-treatedRecombinant Mouse IL-12 Cures CD40LKO
Mice of L. major Infection CD40LKO mice, there was a dose-dependent increase in
IFNg levels that paralleled the level of disease resistanceThe inability of T cells from L. major±infected CD40LKO
mice to stimulate IL-12 secretion from APCs suggested conferred by IL-12 treatment (Figure 4B). Cultures of
Immunity
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Figure 5. Recombinant CD40L Diminishes the Severity of L. major
Infection in CD40LKO Mice
In three separate experiments (A±C), recombinant CD40L was ad-
ministered by subcutaneous injection at the base of the tail for 7
consecutive days beginning on the day of infection. CD40LKO mice
received (A) 50 mg/day CD40L, (B) 50 mg/day, 100 mg/day, or 150
mg/day CD40L, and (C) 10 mg/day or 50 mg/day CD40L. In each
experiment, control mice were injected subcutaneously with PBS
containing 10% glycerol. Each measurement represents the mean
change in footpad size 6 SEM for 5 mice/group. The asterisk repre-Figure 4. Administration of Exogenous Mouse IL-12 Ablates the
sents the point at which mice were sacrificed due to ulceratingProgression of Cutaneous Leishmaniasis in CD40LKO Mice
lesions.
(A) CD40LKO mice received intraperitoneal injections of either 0.5
mg or 1 mg IL-12 for 7 consecutive days beginning on the day of
levels of various cytokines, including IL-12, IFNg, IL-4,infection with L. major promastigotes. BALB/c were treated with 0.5
mg/day of IL-12, and control (C57BL/6 3 129/J)F1, BALB/c, and IL-10, and transforming growth factor-b, may actually
CD40LKO mice received daily placebo injections intraperitoneal of determine disease severity (Scharton-Kersten et al.,
5 mg/day MSA in PBS. Footpad measurements represent the mean 1995).
change in footpad swelling 6 SEM for 5 mice/group. Asterisks repre-
sent the time at which animals were sacrificed due to ulcerating
Recombinant Soluble CD40L Diminisheslesions.
Lesion Size in L. major±Infected(B) IFNg production by lymph node cells isolated from IL-12-treated
CD40LKO mice. Popliteal lymph node cells harvested from infected CD40LKO Mice
mice were stimulated in vitro with 20 mg/ml SLA for 72 hr. Culture We sought to determine whether exogenously adminis-
supernatants were assayed for IFNg by ELISA as described in Exper- tered CD40L could restore disease resistance in
imental Procedures.
CD40LKO mice. In three separate experiments (Figure
5), recombinant CD40L was injected subcutaneously at
cells from CD40LKO mice cured by treatment with 1 the base of the tail for 7 days postchallenge with L.
mg/day IL-12 contained a 24-fold higher concentration major, and disease progression was assessed. Increas-
of IFNg than cultures from untreated CD40LKO mice. ing doses of recombinant CD40L caused a correspond-
Interestingly, these animals synthesized as much IFNg ing decrease in lesion size. Compared with untreated
as untreated BALB/c mice, yet IL-12-treated CD40LKO CD40LKO mice, mice receiving 150 mg/day of CD40L
mice were resistant and BALB/c were susceptible. It is showed, on average, a 42% reduction in lesion size
important to note that although IFNg is necessary for between 4±5 weeks after initiation of infection (Figure
protection against L. major (Belosevic et al., 1989), the 5B). Although treatment with recombinant CD40L de-
presence of IFNg does not necessarily guarantee dis- layed the disease process, the animals eventually devel-
oped progressive disease.ease resistance (Morris et al., 1993). Rather, the relative
Leishmaniasis, CD40 Ligand, and IL-12
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Discussion cells with CD40 on IFNg primed monocytes/macro-
phages induces IL-12 secretion (Shu et al., 1995; Ken-
nedy et al., 1996). We demonstrate that antigen-acti-In this study, we demonstrate that the cell-surface mole-
vated T cells from infected CD40LKO mice are unablecule CD40L is required to generate a protective cell-
to stimulate macrophage IL-12 production even in themediated immune response to L. major. Unrestricted
presence of exogenous IFNg. Thus, we propose thatgrowth of the parasite and development of ulcerating
during infection of resistant strains of mice, APCs pres-cutaneous lesions occurred in naturally resistant mice
ent leishmanial antigens to T cells, resulting in activa-lacking CD40L expression. The susceptible phenotype
tion-induced expression of CD40L. CD40L, likely in com-of CD40LKO mice was associated with a failure to gener-
bination with IFNg, induces IL-12 production by theate a predominant IFNg-secreting Th1-like cell popula-
APCs, initiating or amplifying the cascade of events de-tion. This observation was consistent with previous
scribed previously. CD40L may also have direct effectsstudies demonstrating that resistance to L. major in vari-
upon macrophage microbicidal mechanisms, particu-ous mouse strains strongly correlates with the develop-
larly at the level of nitric oxide synthesis (Tian et al.,ment of a Th1-like cytokine secretion profile (Sadick et
1995; Stout et al., 1996). Finally, T cells can expressal., 1986; Belosevic et al., 1989; reviewed by Reiner and
both CD40L and low levels of CD40, and T cell activationLocksley, 1995). The results in this study indicate that
signals can be transduced through either moleculethe connection between CD40L and development of a
(Armitage et al., 1993; van Essen et al., 1995). Thus, the
Th1 cell-mediated immune response may be at the level
absence of CD40L might directly affect T cell differenti-
of T cell±dependent IL-12 production, a process that is
ation.
defective in CD40LKO mice. A requirement for CD40L-mediated signals in IL-12
Both IL-12 and IFNg are required for effective resolu- production suggests that recombinant CD40L may have
tion of leishmaniasis (Belosevic et al., 1989; Heinzel et therapeutic use in the control of infectious diseases in
al., 1995), and each of these cytokines appears to have which IL-12 plays a role in host defense (Locksley, 1993).
positive effects on the production of the other (Gazzinelli Under the restricted conditions employed in this study,
et al., 1993; Macatonia et al., 1993). Based upon these recombinant CD40L given during the first week of infec-
and other observations, the following paradigm has tion delayed and inhibited swelling of the hind footpad
been proposed toexplain the process that occurs during in a dose-dependent manner. The combination of re-
a protective Th1 cell-mediated response to L major. combinant CD40L and a suboptimal dose of IL-12 pro-
Upon invasion by promastigotes, macrophages release vided more protection to CD40LKO mice than injection
IL-12, which first induces natural killer (NK) cells to se- of either one alone (data not shown). In addition to its
crete IFNg, and second, in combination with IFNg drives potential clinical applications, recombinant CD40L will
CD41 T cell differentiation toward the Th1-like pathway be a valuable tool in investigating the temporal require-
(Scharton-Kersten and Scott, 1995). Mature Th1 cells ments for CD40L and its mechanism of action in cell-
expand in number and release more IFNg, which in- mediated immune responses.
creases IL-12 production by APCs (Murphy et al., 1994)
Experimental Proceduresand activates macrophage parasiticidal mechanisms
(Ding et al., 1988; Gazzinelli et al., 1994).
Mice
Some aspects of this paradigm are not well estab- C57BL/6 and BALB/c mice were obtained from Charles River Labo-
lished. For example, there is some controversy regard- ratories (Wilmington, Massachusetts). 129/J and (C57BL/6 3 129/
J)F1 hybrid mice were obtained from the Jackson Laboratory (Baring the ability of L. major promastigotes to initiate IL-12
Harbor, Maine). CD40LKO mice were generated at Immunex Corpo-production directly upon invasion of host macrophages
ration by homologous gene disruption as described (Renshaw et(Reiner et al., 1994; Scharton-Kersten et al., 1995). It
al., 1994), and the colony was maintained as random hybrids of
is also unclear whether the production of IFNg occurs C57BL/6 3 129/J. All mice were maintained under specific patho-
before or after the appearance of IL-12 in L. major infec- gen-free conditions and used at 8±12 weeks of age.
tions (Reiner et al., 1994; Scharton-Kersten et al., 1995).
Parasites and Soluble Antigen PreparationOptimal production of IL-12 requires IFNg (Gazzinelli et
L. major (WHO MHOM/IL/80/Friedlin strain) was cultured in Medium
al., 1993; Dighe et al., 1995; Flesch et al., 1995; Hayes 199 supplemented with 10% fetal bovine serum, 100 mM penicillin,
et al., 1995; Skeiky et al., 1995), suggesting a possible 100 mM streptomycin, and 2 mM L-glutamine. Stationary phase
promastigotes were resuspended in endotoxin-free phosphate-buf-requirement for IFNg early in the response. IFNg is, in
fered saline (PBS) containing 2% glucose. Mice were infected in thefact, produced early after L. major infection, presumably
hind footpad with 2±5 3 105 promastigotes in a 25 ml volume. Theby NK cells (Scharton and Scott, 1993), and early IFNg course of infection was monitored by measuring the change in foot-
production may be IL-12 independent (Reiner et al., pad thickness between the infected foot and the contralateral foot
1994). Nonetheless, IL-12-driven IFNg production, either using a Starrett spring loaded metric caliper (Athol, Massachusetts).
Footpad measurements were performed three times a week. SLAby NK cells or Th1 cells, is a key component in antileish-
was prepared by a freeze±thaw method as described (Reed et al.,manial responses.
1986), and total protein concentration in SLA preparations was as-
Where does CD40L fit into this process? We demon- sessed using a Pierce bicinchoninic acid proteinassay kit (Rockford,
strate that the requirement for CD40L can be bypassed Illinois). SLA was filtered, aliquoted, and kept frozen at 2208C
until use.by exogenous IL-12. Therefore, in normally resistant
mice, CD40L must act prior to the appearance of func-
Cytokines and Reagentstionally effective quantities of endogenous IL-12. What Recombinant mouse IL-12 and goat anti-mouse IL-12 were provided
is the connection between CD40L and IL-12? Previous by Dr. M. Gately (Hoffmann-LaRoche, Nutley, New Jersey). The IL-
12 was diluted in Dulbecco's PBS (GIBCO BRL, Grand Island, Newstudies have shown that the interaction of CD40L on T
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York) containing 25 mg/ml mouse serum albumin (Sigma, St. Louis, with an IL-12 standard curve. The sensitivity of the bioassay was
0.1±0.4 pg/ml IL-12.Missouri) for in vivo injection. Purified rat anti-mouse IL-10 (JES5-
2A5) was purchased from PharMingen (San Diego, California). Ham-
ster anti-mouse CD3 MAb (500A2, gift of Dr. J. P. Allison, University Acknowledgments
of California at Berkeley, Berkeley, California) and polyclonal sheep
anti-mouse IL-2 were prepared at Immunex. The expression plasmid The authors gratefully acknowledge the expert technical assistance
used to generate recombinant CD40L contained a cDNA insert con- of K. S. Picha and J. L. Smith. We wish to thank Dr. M. K. Gately
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quence with an attached leucine zipper motif, which rendered the to especially thank Drs. S. Reiner (University of Chicago, Chicago,
recombinant protein oligomeric. Recombinant CD40L was purified Illinois), R. Armitage, M. Kubin, and M. Widmer (Immunex Corpora-
from the supernatant of transfected CHO cell supernatants (Fanslow tion, Seattle, Washington) for critical review of the manuscript, and
et al., 1994) and was shown to contain 1±4 pg endotoxin/mg protein. A. C. Bannister, editor in life sciences, for editorial assistance.
For in vivo administration, recombinant CD40L was resuspended
in Dulbecco's PBS containing 10% glycerol. Purified recombinant Received September 11, 1995; revised January 17, 1996.
mouse IL-4 and GM±CSF were prepared at Immunex, and purified
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